Fen Lai Tan
Director/Board Member at Capio Biosciences, Inc.
Profile
Fen Lai Tan is currently a Director at Capio Biosciences, Inc. Prior to this, he worked as a Director, Chief Medical Officer & Senior VP at Betta Pharmaceuticals Co., Ltd.
from 2013 to 2018.
Dr. Tan holds a doctorate degree from The University of Arkansas.
Fen Lai Tan active positions
| Companies | Position | Start |
|---|---|---|
Capio Biosciences, Inc.
 Capio Biosciences, Inc. BiotechnologyHealth Technology Capio Biosciences, Inc. operates as biotech company, designs and develops OncoSense CTC technology that removes circulating tumor cells from a patient's liquid biopsy. The company was founded in 2015 by Seungpyo Hong and Andrew Wang and is headquartered in Madison, WI. | Director/Board Member | - |
Former positions of Fen Lai Tan
| Companies | Position | End |
|---|---|---|
| BETTA PHARMACEUTICALS CO., LTD. | Chief Tech/Sci/R&D Officer | 25/03/2018 |
Training of Fen Lai Tan
| The University of Arkansas | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BETTA PHARMACEUTICALS CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Capio Biosciences, Inc.
Capio Biosciences, Inc. BiotechnologyHealth Technology Capio Biosciences, Inc. operates as biotech company, designs and develops OncoSense CTC technology that removes circulating tumor cells from a patient's liquid biopsy. The company was founded in 2015 by Seungpyo Hong and Andrew Wang and is headquartered in Madison, WI. | Health Technology |
- Stock Market
- Insiders
- Fen Lai Tan
